Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-034068

Chief Financial Officer gave up 9,451 shares (to pay taxes)

  • Chief Financial Officer acquired 33,188 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ruffo Frank Chief Financial Officer 2020-06-01 Option exercise +33,188 221,143 D
Ruffo Frank Chief Financial Officer 2020-06-01 Shares withheld for taxes −9,451 $1.32 $12,475 211,692 D
Derivatives
Ruffo Frank Chief Financial Officer 2020-06-01 Option exercise · Restricted stock units −33,188 33,189 D
Loading xslF345X03/doc4.xml…